Kevin Foley PhD

Kevin is an experimental biologist with expertise in biochemistry, cell biology, and physiology. He has over 10 years’ experience studying metabolic and inflammatory disease, with focus on Type 2 Diabetes and aging. In his work, Kevin has developed both in vivo and in vitro models and published 28 peer-reviewed scientific papers. His postdoctoral work at McMaster University in Ontario, Canada focused on host-microbe interactions in regulating glucose homeostasis during the progression of insulin resistance. Kevin’s expertise supports Siolta’s on-going development of therapeutics to address metabolic disease.